Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HID1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OTOP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDR2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USH1G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL58 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP5H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FDXR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRIN2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM104 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAT9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC9A3R1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on